𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Enhancement of the antiproliferative effect of cis-diamminedichloroplatinum(II) and nitrogen mustard by inhibitors of protein kinase C

✍ Scribed by Johann Hofmann; Wolfgang Doppler; Axel Jakob; Karl Maly; Lydia Posch; Florian Überall; Hans H. Grunicke


Publisher
John Wiley and Sons
Year
1988
Tongue
French
Weight
769 KB
Volume
42
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Quercetin (3,3',4',5,7-pentahydroxyflavone) has been shown to inhibit a variety of enzymes including the calcium- and phospholipid-dependent protein kinase (protein kinase C) in vivo and in vitro. We show that this compound synergistically enhances the antiproliferative activity of cis-diamminedichloroplatinum(II) (cis-DDP) and nitrogen mustard. Quercetin does not affect the repair of DNA interstrand cross-links introduced by cis-DDP. Long-term exposure to 12-O-tetradecanoylphorbol-13-acetate (TPA), which reduces total protein kinase C activity, also amplifies the growth-inhibitory effect of cis-DDP and acts synergistically with quercetin. A synergism is also observed if tamoxifen or staurosporine are combined with cis-DDP. For both drugs the dose-effect curves for the inhibition of protein kinase C closely resemble the dose-effect curves for the antiproliferative activities. Although alternative mechanisms cannot be definitively excluded, the effects of quercetin, TPA, tamoxifen and staurosporine may result from the inhibition of protein kinase C.


📜 SIMILAR VOLUMES


Enhancement of the antiproliferative act
✍ Johann Hofmann; Heiner H. Fiebig; Bernd R. Winterhalter; Dietmar P. Berger; Hans 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 395 KB

We have shown previously that the flavonoid quercetin (3,3',4',5,7-pentahydroxyflavone) enhances the antiproliferative activity of cis-diamminedichloroplatinum(l1) (cis-DDP) in vitro. in order to investigate whether this observation could be exploited in cancer treatment, we tested this drug combina

Galantamine enhancement of long-term pot
✍ Shigeki Moriguchi; Norifumi Shioda; Feng Han; Jay Z. Yeh; Toshio Narahashi; Kohj 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 652 KB

## Abstract Galantamine, a novel Alzheimer's drug, is known to inhibit acetylcholinesterase activity and potentiate nicotinic acetylcholine receptor (nAChR) in the brain. We previously reported that galantamine potentiates the NMDA‐induced currents in primary cultured rat cortical neurons. We now s

Inhibition of protein kinase C and calmo
✍ Catherine A. O'Brian; Constantin G. Ioannides; Nancy E. Ward; Rob M. Liskamp 📂 Article 📅 1990 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 648 KB

## SYNOPSIS The triphenylethylene antiestrogen trans-tamoxifen is an effective antitumor agent used in the treatment of human breast cancer. While the antiestrogenic activity of trans- tamoxifen clearly plays an important role in its tumoricidal action, some of the biological effects of trans-tamo

Reduced calcium and inhibition of protei
✍ Ibrahim, Ragaa H. ;Platt, James E. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 711 KB

## Abstract We previously reported that prolactin (PRL) could increase the activity of ornithine decarboxylase (ODC) in liver slices taken from larval tiger salamanders (__Ambystoma tigrinum__). This action of the hormone was inhibited by oxytocin (OT), the calcium ionophore A23187, and diacyglycer